🔗 Share this article

Treasury head Rachel Reeves has revealed she is preparing "focused measures to tackle household expense pressures" in next month's financial statement.

Speaking to media outlets, she emphasized that lowering price rises is a joint task of both the administration and the Bank of England.

The UK's price growth is projected to be the highest among the G7 industrialized countries this calendar year and the following year.

Possible Utility Cost Measures

Reports indicate the government could intervene to bring down utility costs, for instance by reducing the present 5% rate of value-added tax charged on energy supplies.

An additional option is to cut some of the policy costs presently included in household expenses.

Fiscal Limitations and Analyst Expectations

The administration will obtain the next report from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will reveal how much space there is for these actions.

The consensus from most economists is that the Chancellor will have to introduce tax increases or budget cuts in order to adhere to her declared debt limits.

Previously on the same day, calculations showed there was a twenty-two billion pound shortfall for the Treasury chief to address, which is at the more modest range of expectations.

"It is a collective task between the Bank of England and the administration to bear down further on some of the sources of price increases," the Chancellor told the BBC in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.

Revenue Commitments and International Concerns

While a great deal of the attention has been on likely tax rises, the chancellor said the most recent data from the OBR had not altered her vow to campaign commitments not to increase tax levels on income tax, VAT or National Insurance.

She blamed an "uncertain global environment" with rising geopolitical and commercial concerns for the fiscal tax moves, probably to be directed on those "most able to pay."

Global Economic Tensions

Referring to concerns about the United Kingdom's economic relations with the Asian nation she said: "The UK's national security invariably are paramount."

Recent declaration by Chinese authorities to tighten trade restrictions on rare earths and other resources that are essential for high-technology manufacturing led American leader the US President to suggest an additional 100% tariff on imports from China, raising the possibility of an all-out trade war between the two largest economies.

The American finance chief called the Chinese move "economic coercion" and "a global supply chain control attempt."

Asked about considering the American proposal to join its battle with the Asian nation, the Chancellor said she was "deeply worried" by China's measures and urged the Chinese government "not to put up barriers and limit trade."

She said the decision was "bad for the world economy and generates further challenges."

"It is my opinion there are areas where we need to confront China, but there are also important prospects to sell into China's economy, including banking sector and other areas of the economic system. We've got to achieve that balance correct."

The chancellor also affirmed she was cooperating with other major economies "regarding our own essential resources plan, so that we are reduced dependence."

Health Service Medicine Costs and Investment

Reeves also recognized that the price the National Health Service spends on drugs could go up as a consequence of ongoing talks with the US government and its drugs companies, in exchange for lower tariffs and capital.

Some of the biggest global drug companies have said in recent statements that they are either delaying or scrapping operations in the United Kingdom, with several attributing the low prices they are receiving.

Recently, the government science advisor said the cost the NHS pays for drugs would have to go up to stop companies and pharmaceutical investment leaving the UK.

The Chancellor informed the BBC: "We have seen due to the pricing regime, that clinical trials, new drugs have not been available in the United Kingdom in the manner that they are in other European countries."

"Our aim is to make sure that people getting care from the NHS are able to obtain the best life-saving medicines in the globe. And so we are examining this situation, and... aiming to obtain additional funding into the UK."